Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
Immatics US, Inc.
HRYZ Biotech Co.
Fate Therapeutics
Genocea Biosciences, Inc.
Emory University